- AU$51.80m
- AU$41.85m
- AU$1.43m
Australia's Singular Health gains on collaboration deal with Osteopore
Brief: Singular Health Signs Collaboration Deal With Osteopore To Procure 4 Enterprise Licenses For 3Dicom
Australia Stock Exchange release from SINGULAR HEA : AE Commissions Medical Manufacturing Facility
Australia Stock Exchange release from SINGULAR HEA : PRE_NR Ends: 09:49:02
Australia Stock Exchange release from SINGULAR HEA : OSX: Commences AI-Powered Design Study for Cranial Implants
Australia Stock Exchange release from SINGULAR HEA : SHG & CSIRO AI Tool to Optimise Cranial Implant Procedures
Australia Stock Exchange release from SINGULAR HEA : PRE_NR Ends: 08:30:08
Australia Stock Exchange release from SINGULAR HEA : Half Year Accounts
Australia Stock Exchange release from SINGULAR HEA : PRE_NR Ends: 19:16:57
Brief: Singular Health Says Entered A 50/50 Joint Venture In Macau With A Strategic Investor
Australia Stock Exchange release from SINGULAR HEA : PRE_NR Ends: 10:11:00
Australia Stock Exchange release from SINGULAR HEA : China-based JV Formed and 3Dicom trial at Macau Hospital
Australia Stock Exchange release from SINGULAR HEA : R&D Tax Incentive FY2021 Refund Received
Australia Stock Exchange release from SINGULAR HEA : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from SINGULAR HEA : PRE_NR Ends: 16:56:31
Australia Stock Exchange release from SINGULAR HEA : Notification regarding unquoted securities - SHG
Australia Stock Exchange release from SINGULAR HEA : Restricted Securities to be Released from Escrow
Australia Stock Exchange release from SINGULAR HEA : Application for quotation of securities - SHG
Australia Stock Exchange release from SINGULAR HEA : Appendix 3Y - Change of Director's Interest Notice